Announcements Trials
Browse Landscape

Phase

Phase 2 67Phase 3 53Phase 1 18Phase 2/3 4Phase NA 3Phase 1/2 3Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 22INDUSTRY 9OTHER_GOV 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

sintilimab 1diphtheria-tetanus-five component acellular pertussis-inactivated poliomyelitis -Haemophilus influenzae type b conjugate vaccine 1Vincristine 1Sevoflurane 1Rituximab 1Propofol 1Pleurodesis 1Mitoxantrone 1Methotrexate 1Introns 1Interferon alpha-2 1Idarubicin 1Gastrointestinal Microbiome 1Drug Therapy 1Docetaxel 1Dexamethasone 1Dasatinib 1Danazol 1Cytarabine 1Clorazepate Dipotassium 1Carboplatin 1Anesthesia, Epidural 123-valent pneumococcal capsular polysaccharide vaccine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × NETWORK × Carboplatin × Clear all
NCT00883675 2013-12-18

Safety Study of Adjuvant Docetaxel-Carboplatin Treatment for Resected Lung Cancer

Maestro Clinical, Inc.

Phase 4 Completed
133 enrolled 8 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡